Detalhe da pesquisa
1.
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group.
Semin Arthritis Rheum
; 64: 152340, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071831
2.
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023.
Semin Arthritis Rheum
; 66: 152438, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555726
3.
Embracing unity at OMERACT: Valuing equity, promoting diversity, fostering inclusivity.
Semin Arthritis Rheum
; 66: 152422, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461757
4.
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set.
Semin Arthritis Rheum
; 64: 152343, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38118370
5.
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments.
Semin Arthritis Rheum
; 65: 152344, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38232625
6.
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.
Arthritis Rheumatol
; 75(3): 333-348, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597810
7.
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.
Arthritis Care Res (Hoboken)
; 75(3): 449-464, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597813